ExcellGene is a Contract Service, CMO/CDMO, Generics/Biosimilars Manufacturer company operating in the pharmaceutical industry.
Global leader in cell line and process development. We create high yielding (5-14 g/L) CHO and HEK293 cell lines and can work with any protein format (mAb, bi-specific, Fc-fusion, viral protein, AAV, etc.). We also design the entire manufacturing process, scale it up to 200L, manufacture tox batches, and create cGMP Master Cell Banks. Through trusted CMO partners, we deliver GMP Drug Substance to you in 9-12 months, starting from DNA. Note: we also supply ready-to-use cell lines & processes for biosimilars (4.5 – 7g/L)
Company type
Contract Service, CMO/CDMO, Generics/Biosimilars Manufacturer
Products and services
Biopharmaceuticals, APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries)
Useful Links
Connect with ExcellGene on LinkedIn
Address
ExcellGene, Route de l’Ile-au-Bois 1 A, Monthey, Valais, Switzerland, 1870
